Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease

In recent years, with the advancement of next-generation sequencing (NGS) technology, gene panel tests have been approved in the field of cancer diseases, and approaches to prescribe optimal molecular target drugs to patients are being developed. In the field of rare diseases, whole-genome and whole...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yuichi, Kanayama, Norihiro, Nakayama, Yusuke, Matsushima, Nobuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949099/
https://www.ncbi.nlm.nih.gov/pubmed/35330444
http://dx.doi.org/10.3390/jpm12030444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949099/
https://www.ncbi.nlm.nih.gov/pubmed/35330444
http://dx.doi.org/10.3390/jpm12030444

Ejemplares similares